COVID-19 vaccine from Oxford shows positive results
International

COVID-19 vaccine from Oxford shows positive results

A potential COVID-19 vaccine developed by Oxford University with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial, according to newly released data published Monday in the medical journal The Lancet. The researchers are calling their experimental vaccine ChAdOx1 nCoV-19 (AZD1222)

vaccine trial oxford coronavirus

Mon Jul 20 - CNBC

Related Articles

India reports 83,000 new coronavirus cases
International
India reports 83,000 new coronavirus cases

India recorded 83,341 COVID-19 cases in the last 24 hours along with 1,096 deaths. India’s total coronavirus cases passed 3.9 million, now just behind Brazil with 4 million cases. The US topped the list with more than 6 million coronavirus cases. India’s case fatality rate of 1.75% is well below the global average of 3.3%, the ministry said. Experts have questioned whether some Indian states have undercounted deaths

india deaths coronavirus covid19 cases covid

Fri Sep 04 - AP
India reports 76,000 new coronavirus cases
International
India reports 76,000 new coronavirus cases

India reported a new record of daily infections on Wednesday as more than 76,000 tested positive across the country. Simultaneously, fatalities also crossed 60,000 yesterday, which means the South Asian country has the fourth-highest death toll in the world. India has confirmed more than three million cases so far, with the latest million taking just 15 days to reach

india coronavirus covid19 cases

Thu Aug 27 - BBC
Here's Why Buying Coronavirus Stocks Can Be Risky
International
Here's Why Buying Coronavirus Stocks Can Be Risky

Many of the hottest stocks on the markets right now are those of companies developing potential vaccines or treatments for COVID-19, or businesses that are well-suited to the transformed economic conditions of the coronavirus pandemic. While new COVID-19 cases may continue to pop up for many years, investors shouldn't assume the pandemic is a long-term situation and ought to avoid investing based on that assumption.

vaccine heres risky

Wed Aug 19 - Fool
Novavax Launches Midstage Coronavirus Vaccine Trial
International
Novavax Launches Midstage Coronavirus Vaccine Trial

Vaccine specialist Novavax (NASDAQ:NVAX) announced the launch of a phase 2b clinical trial in South Africa to test the effectiveness of its coronavirus vaccine, NVX-CoV2373. Novavax is somewhat behind the leaders in the race for an approved vaccine for COVID-19, but the level of transmission in South Africa may give the company a chance to evaluate the efficacy of its vaccine very quickly.

vaccine novavax midstage

Wed Aug 19 - Fool